Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Aveanna Healthcare Holdings Inc.

Stage 2 · Advancing · week 13

As of Oct 22, 2026, Aveanna Healthcare Holdings is in Stage 2, the uptrend phase, now in week 13 (since Jul 23, 2026). It closed at $13.32, 7.4% below its 52-week high and above its 200-day average, which is rising.

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. More about the company

$13.32
+0.94% today
$2.9B · Mid cap
Market Neutral — Fading

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 17 in Medical Care Facilities · #1 of 272 in Health Care

Is AVAH early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S2 14w
S2 26w
S2 18w
S2 13w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 4w → S3 6w → S4 3w → S2 14w → S3 7w → S2 2w → S3 3w → S2 26w → S3 1w → S2 5w → S3 12w → S2 3w → S1 2w → S4 1w → S1 1w → S2 5w → S3 5w → S4 4w → S1 1w → S2 18w → S3 13w → S4 9w → S1 7w → S2 13w current
Total tracked: 164 weeks across 24 stage runs.

AVAH among Medical Care Facilities18th of 49 by relative strength

All 49 →
Stocks in Medical Care Facilities ranked by relative strength, with stage and one-month change
#StockStageRS1M
1AGLStage 3 · wk 898+6.8%
2PACSStage 3 · wk 498+15.7%
3LFSTStage 2 · wk 2497+4.0%
4AMNStage 2 · wk 2596+38.1%
5NHCStage 2 · wk 5995+8.4%
6CONStage 2 · wk 2294+14.9%
7INNVStage 3 · wk 593+5.8%
8MDStage 2 · wk 2692+14.3%
…18AVAHStage 2 · wk 1377+4.1%
vs 52W High
-7.4%
$6.22 lo$14.38 hi
7.4% below 52W high, pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 13
1w13w26w
Week 13, proven structure
How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.
vs 200 DMA
46.3%
200 DMA: $9.10 · rising
Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.
Rel Volume
0.52x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+4.1%
3M
+41.0%
6M
+104.6%
YTD
+64.9%
1Y
+30.2%
Scan Membership
Breakout Watch
Latest: 2025-03-27
6 appearances in last 60 days. First seen: 2023-06-21.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S2
Wk 13 · Vol 0.52x
2026-10-21S2
Wk 13 · Vol 0.71x
2026-10-20S2
Wk 13 · Vol 0.52x
2026-10-19S2
Wk 13 · Vol 0.48x
2026-10-16S2
Wk 13 · Vol 0.69x
2026-10-15S2
Wk 12 · Vol 0.55x
2026-10-14S2
Wk 12 · Vol 0.60x
2026-10-13S2
Wk 12 · Vol 0.55x
2026-10-12S2
Wk 12 · Vol 0.52x
2026-10-09S2
Wk 12 · Vol 0.50x
2026-10-08S2
Wk 11 · Vol 0.74x
2026-10-07S2
Wk 11 · Vol 1.40x
Moving averages & range
50 DMA
$13.04
200 DMA
$9.10
52W High
$14.38
52W Low
$6.22
5D Low
$12.34
Resistance levels (recent highs)
20d High
$13.32
60d High
$14.38
120d High
$14.38
250d High
$14.38
Next resistance
+8.0%
to 60d High
P/E (TTM)
10.6
Forward 14.7
Earnings Growth (YoY)
+38.5%
Revenue +13.7%
ROE
+198.6%
Profit margin +10.6%
Dividend Yield
0.00%
P/B 10.1

Aveanna Healthcare Holdings: quick answers

What stage is Aveanna Healthcare Holdings in?

As of Oct 22, 2026, Aveanna Healthcare Holdings (AVAH) is in Stage 2, the uptrend phase. It entered Stage 2 on Jul 23, 2026 and is in week 13. What the four stages mean

Is Aveanna Healthcare Holdings in an uptrend?

Yes. Aveanna Healthcare Holdings is in a Stage 2 uptrend. It trades 46.3% above its 200-day average, which is rising.

How far is Aveanna Healthcare Holdings from its 52-week high?

Aveanna Healthcare Holdings closed at $13.32 on Oct 22, 2026, 7.4% below its 52-week high of $14.38. Its 52-week low is $6.22.

How has Aveanna Healthcare Holdings performed over the past year?

As of Oct 22, 2026, Aveanna Healthcare Holdings is up 30.2% over the past year and up 64.9% so far in 2026.

Which sector and industry is Aveanna Healthcare Holdings in?

Aveanna Healthcare Holdings is in the Medical Care Facilities industry, part of the Health Care sector.

About this companyHealth Care· Medical Care Facilities

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.